We are exploring,
and commercializing


Today in Puls Biznesu you can read about our fund. “Ok. But what is the probability that your idea will work out?” “I do not know, I have to check it out.” This question was asked by Konrad Pankiewicz over two years ago, and the answer was given by Dr. Filip Granek “…. https://www.pb.pl/reaktor-dobrej-energii-867462


KRYNICA 2019 – Startup Session Elite. Podium for two companies from our portfolio.

During this year’s Economic Forum in Krynica, the best Startups were awarded in the Startup Elite Session competition. We’re very pleased to inform you that the top three included two startups from Leonarto’s portfolio. Congratulations for Biotts and ChallengeRocket.com for this prestigious award! We keep our fingers crossed for further development! https://www.forum-ekonomiczne.pl/gala-zamykajaca-xxix-forum-ekonomiczne/


XTPL, next step on the path to commercialization

Choosing the right business model is next to the right timing and good team, the most important reason why start-up success factor for a startup succeed. The Management Board of XTPL, supported by the Advisory Board, has repeatedly proved that the adopted vision of the company’s development and the strategy of its implementation brings the […]


Bioceltix and Nestmedic regarded as ones of the most interesting HealthTech projects by Mamstartup.pl

The largest polish service MamStartup.pl reviewing startup industry, chose the most interesting healthtech projects offering completely new opportunities and allowing significant improvement of standards in the medical industry. Among the awarded projects are two companies from Leonarto’s portfolio. The first one is Bioceltix with innovative medicines for animals, using allogeneic stem cells to treat atopic […]


Bioceltix presents its product development plans in an interview for Animal Pharm

Bioceltix plans to achieve EU Good Manufacturing Practise certification by the end of 2019. This certificate entitles to start the production process of the first candidates for medicines. The company is trying to obtain it for stem cell-based medicines for dogs suffering from atopic dermatitis and cancer changes such as leukaemia or lymphoma. “By the […]


The development of a nanotechnology startup requires taking effective action on many fronts: R&D activities, cooperation with international patent office in the field of intellectual property protection, fundraising, establishment of contacts with scientific and industry partners at home and abroad. In all these areas we can count on the great support and active involvement of the Leonarto team. The way the Leonarto team works, perfectly reflects the meaning of the phrase “smart money”.

Filip Granek CTO and CO-FOUNDER at XTPL

Leonarto is for Bioavlee an invaluable partner in formulating and implementing strategic plans towards sustainable development. The focus on providing an atmosphere of openness that supports unfettered exchange of ideas, views and experiences are the features of our daily relationships. The support and advice of an experienced team of specialists at Leonarto invariably turn out to be very useful for us in building strategic advantages and key operational improvements. The existing cooperation with Leonarto has brought Bioavlee benefits beyond our expectations.

Michał Wronecki CEO at BIOAVLEE

The transition from idea to product (Pregnabit) required a combination of competences and resources from many areas. Getting to the stage where we are today would not be possible without the professional and relational support of the Leonarto team.

Patrycja Wizińska-Socha CO-FOUNDER and CEO at NESTMEDIC

Leonarto is primarily professional entrepreneurs. A flesh and blood business people hardened in market battles. They are people who have gone all the way in building companies from scratch, and they understand the obstacles that are lurking on the way. Thanks to that their support is real. There is no place for purely theoretical, academic mentoring here. We are really helped in moving our business to the wide waters.


Due to the achievements to date in supporting the development of early-stage technology companies in the field of medical solutions, the Leonarto fund was the natural choice for Genomtec. Thanks to the experienced Leonarto team, Genomtec was able to significantly accelerate the development of its technology, and also obtained valuable support in the area of ​​intellectual property protection and development of the Company’s market strategy.

Miron Tokarski CO-FOUNDER and CEO at GENOMTEC

Through marketing and business support, cooperation with Leonarto has allowed us to accelerate the commercialization process and the expansion of sales and business development teams. As a VC fund, Leonarto has a very partnership approach to start-ups and provides invaluable contacts in the capital market.


Leonarto support allows us to look far into the future, refine the strategy and answer difficult questions. In addition to the financial background, we gained a partner who willingly shares his knowledge, experience and business know-how. The vision of a global company has become a plan. Together with Leonarto, we started to implement it.

Krzysztof Sobczak CO-FOUNDER and CEO at EMPLOCITY

Every company at an early stage of development struggles with the basic paradox about how to survive the coming months, and at the same time develop the organization towards the strategic goals. Leonarto managers understand these challenges perfectly, they approach business realistically and ambitiously. They see the current problems that we face every day and support us in creating long-term priorities. What we particularly value in cooperation with Leonarto is directness and honesty. However, in business there is nothing for free: Leonarto gives a lot, but also demands a lot.

Adam Dąbrowski CEO at FUNEDA
18 technological companies

Precisely selected Leonarto | one companies operate in areas with very high growth potential.

Talk – Action = Bullshit